According to Biomerica's latest financial reports the company's current revenue (TTM) is $5.4 M. In 2022 the company made a revenue of $16.08 M an increase over the years 2021 revenue that were of $10.59 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $5.49 M | -65.8% |
2022 | $16.08 M | 51.84% |
2021 | $10.59 M | 65.02% |
2020 | $6.41 M | 23.01% |
2019 | $5.21 M | -1.17% |
2018 | $5.27 M | -12.11% |
2017 | $6 M | 8.63% |
2016 | $5.53 M | 5.41% |
2015 | $5.24 M | -1.75% |
2014 | $5.33 M | 10.42% |
2013 | $4.83 M | -27.2% |
2012 | $6.64 M | 18.93% |
2011 | $5.58 M | 8.13% |
2010 | $5.16 M | 6.1% |
2009 | $4.86 M | -0.11% |
2008 | $4.87 M | -13.44% |
2007 | $5.63 M | 13.72% |
2006 | $4.95 M | -48.82% |
2005 | $9.67 M | 6.53% |
2004 | $9.08 M | -2.01% |
2003 | $9.26 M | 7.52% |
2002 | $8.61 M | -2.31% |
2001 | $8.82 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | $3.86 B | 71,354.42% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | $3.94 B | 72,792.66% | ๐บ๐ธ USA |
Biolase
BIOL | $49.16 M | 809.57% | ๐บ๐ธ USA |